Hemispherx Biopharma Formally Collaborates With the Swiss Department of Defense, Civil Protection and Sports to Study Alferon(R) Against Tamiflu Resistant Influenza Virus Strains
14 mai 2014 08h30 HE
|
AIM ImmunoTech Inc.
PHILADELPHIA, May 14, 2014 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx"), announced that it has entered into a formal collaborative research agreement...
Battelle Introduces Next Generation, Smart Technology for Biodefense and Hazard Avoidance
28 avr. 2014 08h05 HE
|
Battelle
COLUMBUS, OH--(Marketwired - Apr 28, 2014) - Battelle, the world's largest independent research and development organization, today announced production of the next generation chemical and...
PositiveID Corporation Appoints Lyle L. Probst President
21 avr. 2014 08h30 HE
|
PositiveID Corporation
DELRAY BEACH, Fla., April 21, 2014 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (OTCQB:PSID), a developer of biological detection and diagnostics solutions, announced today...
Investorideas.com Security Conference Adds Viscount Systems (OTCQB: VSYS) to Presenters; Speakers Discuss Key Security Issues Including Biodefense, Biometrics and Cybersecurity
20 févr. 2014 14h05 HE
|
InvestorIdeas.com
NEW YORK, NY--(Marketwired - Feb 20, 2014) - Investorideas.com, an investor research and news portal covering leading sectors including technology and defense, announces new speakers and presenters...
Aeolus Announces First Quarter Fiscal Year 2014 Financial Results
14 févr. 2014 17h30 HE
|
Aeolus Pharmaceuticals
MISSION VIEJO, CA--(Marketwired - Feb 14, 2014) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS), a biotechnology company developing compounds to protect against radiological and chemical threats with...
Aeolus Announces Process Improvements and Positive 18 Month Stability Results for AEOL 10150 in New Formulation
13 févr. 2014 07h30 HE
|
Aeolus Pharmaceuticals
MISSION VIEJO, CA--(Marketwired - Feb 13, 2014) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS)
90% reduction in manufacturing cost of drug substance achieved;...
Investorideas.com Security and Defense Conference Adds Biodefense Company PositiveID (OTCQB: PSID) to Presenters: Themes Include Biodefense, Biometrics and Cybersecurity
11 févr. 2014 14h59 HE
|
InvestorIdeas.com
NEW YORK, NY--(Marketwired - Feb 11, 2014) - Investorideas.com, an investor research and news portal covering leading sectors including technology and defense, announces new speakers for its...
Aeolus Announces Publication of Data Demonstrating Efficacy of AEOL 10150 in Animal Model of Lung Radiation Exposure; Models Developed for Pivotal Efficacy Studies
10 févr. 2014 07h30 HE
|
Aeolus Pharmaceuticals
MISSION VIEJO, CA--(Marketwired - Feb 10, 2014) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS)
Three papers published in Health Physics, Volume 106, Number 1 (January 2014)
...
Investorideas.com Security and Defense Conference Adds Kris Tuttle Director of Research for SoundView Technology Group, Cybersecurity and Counterterrorism Analyst Roger Cressey, Homeland Security and Cybersecurity Expert Kiersten Todt, Both of Liberty Group Ventures
24 janv. 2014 10h35 HE
|
InvestorIdeas.com
NEW YORK, NY--(Marketwired - Jan 24, 2014) - Investorideas.com, an investor research and news portal covering leading sectors including technology and defense, announces new speakers for its...
Aeolus Receives Orphan Drug Designation for AEOL 10150 From U.S. FDA
23 janv. 2014 10h52 HE
|
Aeolus Pharmaceuticals
MISSION VIEJO, CA--(Marketwired - Jan 23, 2014) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS), a biotechnology company developing compounds to protect against radiological and chemical threats with...